Plasmapheresis Plasma Exchange for Aging Factor Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Aging-related disorders such as Alzheimer's disease, infections, Type II Diabetes, atherosclerotic cardiovascular disease, obesity, osteoporosis, and sarcopenia impose a significant financial burden on medical systems, and the underlying biochemistry of aging is not fully understood, necessitating effective treatments to improve health status and slow aging.
Innovation Solution
Plasmapheresis methods are employed to measure and modulate cell surface markers, reduce cellular senescence, and remove factors associated with aging, including administering plasmapheresis to exchange plasma volume and infuse exchange fluids like saline, Lactated Ringer's, or albumin, with monitoring for changes in health status and biological age markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plasmapheresis is administered to exchange plasma volume, then health status is improved by removing aging-related factors, but treatment complexity and monitoring requirements increase
Solution Approach 1:
The patent applies preliminary action by measuring health status indicators (strength, balance, mental status, walking ability) before plasmapheresis treatment to establish a baseline. This pre-treatment assessment allows for personalized treatment planning and enables subsequent comparison to evaluate treatment efficacy, thereby managing complexity through structured preparation.
Solution Approach 2:
The patent implements feedback by measuring the same health status indicators after plasmapheresis treatment and comparing post-treatment results with pre-treatment baselines. This feedback mechanism quantifies treatment effectiveness and guides decisions about continuing or modifying the treatment regimen, reducing complexity through data-driven decision making.
2Productivity
If plasmapheresis is administered frequently (within 72 hours), then removal of aging factors is enhanced, but treatment time and resource consumption increase
Solution Approach 1:
The patent applies periodic action by scheduling plasmapheresis treatments at specific intervals (within 72 hours for multiple sessions) based on measured health status responses. This periodic regimen optimizes the removal of aging-related factors while allowing sufficient recovery time between sessions, balancing treatment intensity with resource constraints.
Solution Approach 2:
The patent implements partial action by administering plasmapheresis in controlled sessions (exchanging at least one unit of plasma volume) rather than continuous treatment. The frequency and volume are adjusted based on individual response measurements, allowing effective removal of aging factors while minimizing unnecessary treatment time and resource consumption.
3Measurement precision
If comprehensive health status measurements are performed before and after treatment, then treatment efficacy is accurately determined, but measurement time and procedural complexity increase
Solution Approach 1:
The patent applies universality by using a standardized set of health status measurements (strength via grip strength, balance via single-leg stand, mental status via survey, walking ability via sit-to-walk test) that can be applied to all patients regardless of specific condition. This universal assessment protocol ensures consistent, comparable data across treatments while streamlining the measurement process through standardization.
Solution Approach 2:
The patent implements self-service by designing measurements that patients can perform independently or with minimal assistance (e.g., self-administered mental status survey, self-performed balance and walking tests). This reduces the time and expertise required for administration while maintaining measurement quality, allowing comprehensive assessment without excessive procedural complexity.
Data Source
AI summary
Described herein are compositions and methods for performing plasmapheresis. The compositions and methods for performing plasmapheresis are innovative at least in their application towards the treatment and prevention of aging and conditions associated with aging. Plasmapheresis compositions and methods described herein are directed towards reducing or eliminating conditions associated with aging.